1. Clinical consequences of polymorphic acetylation of basic drugs;Drayer;Clin Pharmacol Ther.,1977
2. Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber;Hein;Drug Metab Dispos.,2000
3. Acetylation as an indicator of risk;Lang;Environ Health Perspect,1997
4. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder;Badawi;Cancer Res.,1995